CrossrefInfokarte
Efficacy, adverse drug reactions, and symptom relief from different doses of tofacitinib combined with methotrexate for rheumatoid arthritis
American Journal of Translational Research · 2026 · 18 (10) · 9138-9147
DOI: 10.62347/ifnx7855 ↗Abstract
Kein Abstract verfügbar.
EUVIMED